COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders


This randomized, multi-site, adaptive, open-label clinical trial will compare the immune response to different COVID-19 vaccine booster doses in participants with autoimmune disease requiring immunosuppressive medications.

To Learn More Contact
Judith A. James, MD, PhD, Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation
Meggan C. Mackay, MD, MS, Center of Autoimmune Musculoskeletal and Hematopoietic Diseases, Feinstein Institute for Medical Research identifier: NCT05000216

Sign up for our Newsletter

Use this tool to search all lupus trials and create a personalized list of studies by the type of lupus you have and where you live.

Sign up